REGISTER RECORD · clinicaltrials.gov

NCT02532400

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

AS THE REGISTER RECORDS IT

Status and dates

Status as listedTERMINATED: terminated before completion
Register last updated2020-03-11
Retrieved by this site2026-08-31
Sourcehttps://clinicaltrials.gov/study/NCT02532400

What this record shows

This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.

All records · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.